Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Infection01:20

Infection

7.7K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Macrophage Efferocytosis in Heart.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Biology and function of exo-polysaccharides from human fungal pathogens.

Current clinical microbiology reports·2020
Same author

Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections.

eLife·2020
Same author

Mechanisms of Pulmonary Escape and Dissemination by Cryptococcus neoformans.

Journal of fungi (Basel, Switzerland)·2018
Same author

Regulated Release of Cryptococcal Polysaccharide Drives Virulence and Suppresses Immune Cell Infiltration into the Central Nervous System.

Infection and immunity·2017
Same author

High-throughput identification and rational design of synergistic small-molecule pairs for combating and bypassing antibiotic resistance.

PLoS biology·2017

Related Experiment Video

Updated: Jun 9, 2025

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
11:07

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans

Published on: December 19, 2014

12.7K

Elements of dissemination in cryptococcosis.

Joseph M Bednarek1, Jessica C S Brown1

  • 1School of Biological Sciences, University of Utah, Salt Lake City, Utah, USA.

Mbio
|October 29, 2024
PubMed
Summary

Cryptococcus neoformans causes deadly fungal meningitis. This review explores how this pathogen disseminates through the host, from initial infection to the central nervous system.

Keywords:
Cryptococcus neoformanscryptococcosisdisseminationfungal meningitismedical mycology

More Related Videos

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

18.8K
Visualizing Non-lytic Exocytosis of Cryptococcus neoformans from Macrophages Using Digital Light Microscopy
10:02

Visualizing Non-lytic Exocytosis of Cryptococcus neoformans from Macrophages Using Digital Light Microscopy

Published on: October 21, 2014

11.8K

Related Experiment Videos

Last Updated: Jun 9, 2025

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
11:07

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans

Published on: December 19, 2014

12.7K
Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

18.8K
Visualizing Non-lytic Exocytosis of Cryptococcus neoformans from Macrophages Using Digital Light Microscopy
10:02

Visualizing Non-lytic Exocytosis of Cryptococcus neoformans from Macrophages Using Digital Light Microscopy

Published on: October 21, 2014

11.8K

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pathogen Biology

Background:

  • Increasing numbers of immunocompromised patients face heightened risks from environmental microbes.
  • Cryptococcus neoformans is a leading cause of fungal meningitis and a WHO priority pathogen.
  • Effective treatment requires understanding dissemination from the environment to the central nervous system (CNS).

Purpose of the Study:

  • To review the dissemination stages of Cryptococcus neoformans.
  • To examine host-fungal interactions during cryptococcal meningoencephalitis.
  • To understand fungal adaptation to diverse host environments.

Main Methods:

  • Review of existing literature on Cryptococcus neoformans pathogenesis.
  • Analysis of host-pathogen interactions during dissemination.
  • Examination of fungal adaptation strategies in vivo.

Main Results:

  • Cryptococcus neoformans disseminates through distinct stages: environmental niche, lungs, bloodstream/lymphatics, and CNS.
  • Host cell interactions are critical for fungal survival and spread.
  • Fungal adaptation is key to overcoming host defenses and establishing infection.

Conclusions:

  • Understanding Cryptococcus neoformans dissemination is crucial for combating cryptococcal meningoencephalitis.
  • Targeting fungal adaptation and host interactions may offer new therapeutic strategies.
  • Further research into the host-pathogen dynamics is essential for improving patient outcomes.